For research use only. Not for use in humans.

Anti-F3 / Factor III / Tissue Factor / CD142 (TNX-832)

Synonyms: F3, Thromboplastin

Anti-F3 / Factor III / Tissue Factor / CD142 (TNX-832) is humanized form of an antibody capable of targeting tissue factor (coagulation factor F3). It is useful in treating conditions, such as tumor progression.MW :144.34 KD.

Anti-F3 / Factor III / Tissue Factor / CD142 (TNX-832)

Quality Control

Batch: A307801 Purity: 99% Protein concentration: 6.19mg/ml Endotoxin Level: <1EU/mg
99

Specificity

Name Citation CD38 CD45 CD39 CD88 CD73 Others
RBN013209 0
MK-0159 0
CD38 inhibitor 1 (compound 78c) 7
AB680 1
NQ301 1 TXA2 receptor
SodiuM Metatungstate 3
PMX-53 3
LY-3475070 2
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Anti-F3 / Factor III / Tissue Factor / CD142 (TNX-832) is humanized form of an antibody capable of targeting tissue factor (coagulation factor F3). It is useful in treating conditions, such as tumor progression.MW :144.34 KD.
References

Product Details

Isotype Human IgG4SP
Source CHO
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT01438853 COMPLETED Drug: Placebo Sepsis; Acute Lung Injury; Acute Respiratory Distress Syndrome Altor BioScience 2004-12 PHASE1

(data from https://clinicaltrials.gov, updated on 2025-01-06)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.